Latest News about CSE:INNO

Recent news which mentions CSE:INNO

CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
Tickers AMZN CBD INNO INNO
Tags Iris Bincovich Benzinga INNO
From Benzinga
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
Tickers INNO INNO INNPF NEWS
Tags Benzinga Cannabis and chronic pain Health Care
From Benzinga
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
Tickers CBD INNO INNO INNPF
Tags Iris Bincovich Benzinga INNO
From Benzinga
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
Tickers CBD INNO INNO INNPF
Tags INNO INNPF Cannabis
From Benzinga
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
Tickers CFO EEX INNO INNO
Tags Rythmia Life Advancement Center Marijuana Business Daily/ CSE:TRUL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.